| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Breakpoint cluster region protein [1-693] |
|---|
| Ligand | BDBM111466 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Kinase Assays |
|---|
| IC50 | 210±n/a nM |
|---|
| Citation |  Pan, X; Dong, J; Gao, H; Wang, F; Zhang, Y; Wang, S; Zhang, J Design, synthesis and biological evaluation of pyridin-3-yl pyrimidines as potent Bcr-Abl inhibitors. Chem Biol Drug Des83:592-9 (2014) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Breakpoint cluster region protein [1-693] |
|---|
| Name: | Breakpoint cluster region protein [1-693] |
|---|
| Synonyms: | BCR | BCR1 | BCR_HUMAN | Bcr-Abl | D22S11 |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 76683.66 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P11274[1-693] |
|---|
| Residue: | 693 |
|---|
| Sequence: | MVDPVGFAEAWKAQFPDSEPPRMELRSVGDIEQELERCKASIRRLEQEVNQERFRMIYLQ
TLLAKEKKSYDRQRWGFRRAAQAPDGASEPRASASRPQPAPADGADPPPAEEPEARPDGE
GSPGKARPGTARRPGAAASGERDDRGPPASVAALRSNFERIRKGHGQPGADAEKPFYVNV
EFHHERGLVKVNDKEVSDRISSLGSQAMQMERKKSQHGAGSSVGDASRPPYRGRSSESSC
GVDGDYEDAELNPRFLKDNLIDANGGSRPPWPPLEYQPYQSIYVGGMMEGEGKGPLLRSQ
STSEQEKRLTWPRRSYSPRSFEDCGGGYTPDCSSNENLTSSEEDFSSGQSSRVSPSPTTY
RMFRDKSRSPSQNSQQSFDSSSPPTPQCHKRHRHCPVVVSEATIVGVRKTGQIWPNDGEG
AFHGDADGSFGTPPGYGCAADRAEEQRRHQDGLPYIDDSPSSSPHLSSKGRGSRDALVSG
ALESTKASELDLEKGLEMRKWVLSGILASEETYLSHLEALLLPMKPLKAAATTSQPVLTS
QQIETIFFKVPELYEIHKEFYDGLFPRVQQWSHQQRVGDLFQKLASQLGVYRAFVDNYGV
AMEMAEKCCQANAQFAEISENLRARSNKDAKDPTTKNSLETLLYKPVDRVTRSTLVLHDL
LKHTPASHPDHPLLQDALRISQNFLSSINEEIT
|
|
|
|---|
| BDBM111466 |
|---|
| n/a |
|---|
| Name | BDBM111466 |
|---|
| Synonyms: | 4-Methyl-3-(4-(pyridin-3-yl) pyrimidin-2-ylamino)-N-(pyrimidin-2-yl) benzamide (A19) |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C22H19N7O |
|---|
| Mol. Mass. | 397.4326 |
|---|
| SMILES | Cc1ccc(cc1Nc1nccc(n1)-c1cccnc1)C(=O)NCc1ncccn1 |
|---|
| Structure | 
|
|---|
Search and Browse
